Clinical trial
A Phase IIb, Randomized, Double-blind, Multicenter Study Evaluating the Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
NCT07624045 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Randomized, Double-blind, Multicenter Study Evaluating the Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle Syndrome
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- January 31, 2029
- Enrollment
- 108 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.